Revolution Medicines, Inc. Restricted Cash remained flat by 0.0% to $4.86M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 31.4%, from $3.70M to $4.86M. Over 5 years (FY 2020 to FY 2025), Restricted Cash shows an upward trend with a 35.0% CAGR.
An increase may signal higher debt service requirements or increased collateral obligations, while a decrease may indicate the release of restricted funds.
Cash balances that are legally or contractually set aside for specific purposes, such as debt service reserves, collater...
Common in capital-intensive industries like energy where project financing requires specific reserve accounts.
restricted_cash| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.08M | $1.08M | $1.74M | $1.74M | $1.74M | $1.74M | $1.74M | $1.74M | $2.59M | $2.39M | $3.03M | $3.03M | $3.03M | $2.89M | $3.70M | $3.70M | $3.92M | $4.86M | $4.86M | $4.86M |
| QoQ Change | — | +0.0% | +60.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +49.3% | -7.8% | +26.8% | +0.0% | +0.0% | -4.7% | +28.0% | +0.0% | +5.9% | +24.1% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +60.2% | +60.2% | +0.0% | +0.0% | +49.3% | +37.7% | +74.5% | +74.5% | +16.8% | +20.8% | +22.0% | +22.0% | +29.2% | +68.2% | +31.4% | +31.4% |